HCPCS Level II · Drugs administered other than oral method
J1030Injection, methylprednisolone acetate, 40 mg
Terminated 03/31/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1030
J1030 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, methylprednisolone acetate, 40 mg.
It was added to HCPCS effective 01/01/1982, and its current record took effect 04/01/2024.
It was terminated on 03/31/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Methylprednisolone 40 mg inj
- Date added
- 01/01/1982
- Action effective
- 04/01/2024
- Termination date
- 03/31/2024
- BETOS
- O1E
Related J10xx codes
- J1000Injection, depo-estradiol cypionate, up to 5 mg
- J1010Injection, methylprednisolone acetate, 1 mg
- J1050Injection, medroxyprogesterone acetate, 1 mg
- J1071Injection, testosterone cypionate, 1 mg
- J1072Injection, testosterone cypionate (azmiro), 1 mg
- J1073Testosterone pellet, implant, 75 mg
- J1095Injection, dexamethasone 9 percent, intraocular, 1 microgram
- J1096Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
- J1097Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
- J1098Articaine ophthalmic, 8% solution, 0.4 ml
Common questions about J1030
Is HCPCS J1030 still valid?
- No. J1030 was terminated on 03/31/2024.
Does Medicare cover J1030?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.